BBLG FY 2022 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

-$1M

EPS (Diluted)

$-31.20

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$266,633

Balance Sheet

Total Assets

$8M

Total Liabilities

$3M

Stockholders' Equity

$6M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$4M	-$1M	-232.3%
Net Income	-$1M	-$2M	+7.8%